SKYSHOWTIME
New streaming service SkyShowtime today announced that it will officially launch on 20 September 2022, bringing its premium offering of exclusive and iconic entertainment to millions of homes across Europe for the first time.
A joint venture of Comcast (NASDAQ: CMCSA) —parent company of NBCUniversal and Sky— and Paramount Global (NASDAQ: PARA, PARAA), SkyShowtime will launch in Denmark, Finland, Norway and Sweden on 20 September, before expanding into the Netherlands later this year in Q4. SkyShowtime will continue its roll out across Spain, Portugal, Andorra, and Central & Eastern Europe (CEE) over the coming months and through Q1 2023. CEE markets include Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Hungary, Kosovo, Montenegro, North Macedonia, Poland, Romania, Serbia, Slovakia and Slovenia. Specific launch dates and pricing in these markets will be announced in the coming months.
SkyShowtime brings together the best entertainment from the world’s greatest studios and storytellers. Featuring thousands of hours of quality entertainment for the whole family, the service will be home to a wide selection of the world’s most highly anticipated series and movies.
It will feature the exclusive television premieres of first-run theatrical films from Paramount Pictures and Universal Pictures, Hollywood’s two oldest studios and which together account for nearly 50% of Hollywood box office.
SkyShowtime will be the home to a selection of new blockbuster films following their theatrical and home entertainment release, including Top Gun: Maverick, Jurassic World Dominion, Minions: The Rise of Gru, The Northman, Sing 2, Sonic the Hedgehog 2, The Lost City, Downton Abbey: A New Era, Nope, Belfast, Ambulance and The Bad Guys.
In addition, SkyShowtime features new premium scripted series, kids and family content and a selection of iconic library titles and box sets from Universal Pictures, Paramount Pictures, Nickelodeon, DreamWorks Animation, Paramount+, SHOWTIME®, Sky Studios and Peacock - all streaming in one place. SkyShowtime will also feature local original programming, documentaries and specials from its markets.
In the Nordics, as part of the partnership with Paramount, SkyShowtime will replace Paramount+, allowing existing and future customers to watch current Paramount+ favourites such as Halo, Yellowstone, The Offer and Star Trek: Strange New Worlds, as well as SHOWTIME® originals Yellowjackets, Dexter: New Blood, Super Pumped: The Battle for Uber, and The First Lady. And for the first time, subscribers will gain access to even more new and exclusive premium series and movies spanning the best of Universal Pictures, Sky Originals and NBCUniversal.
From launch, customers can watch series premieres of highly anticipated SHOWTIME® drama American Gigolo, Sky Originals The Rising, The Fear Index, and The Midwich Cuckoos, as well as Law & Order Season 21 from Peacock. Over the coming months, additional series premieres will include Yellowstone Season 5, Pitch Perfect: Bumper in Berlin, Vampire Academy and SHOWTIME® series Yellowjackets Season 2 and Let The Right One In.
SkyShowtime CEO Monty Sarhan said: “It’s time… for SkyShowtime, — the next great streaming service for Europe. Just months after receiving full regulatory approval, SkyShowtime will officially launch on 20 September 2022. We’re excited for our customers to have exclusive access to the latest series and movie premieres from our iconic and world-renowned studios. We look forward to sharing further details about launch dates for our other markets and bringing SkyShowtime to even more people across Europe.”
SkyShowtime Regional General Manager for Northern Europe Henriette Skov commented: “We’re thrilled to launch SkyShowtime across the Nordics and look forward to offering our customers the very best selection of global series and movies all in one place.”
The service will be available direct-to-consumer via the SkyShowtime app across Apple iOS, tvOS, Android devices, and through the website: www.skyshowtime.com. SkyShowtime’s monthly price will be €6,99 in Finland, SEK 79 in Sweden, NOK 79 in Norway, and DKK 69 in Denmark.
SkyShowtime will also be available through the following distribution partners across its Nordic markets: Allente, RiksTV, Ruutu, Sappa, Strim, Telenor, Tele2, Telia, Telmore and YouSee from Nuuday Group, and TV 2 Play.
Powered by the Peacock platform, SkyShowtime was created specifically for Europe and is dedicated to these markets. With regional offices across its territories, SkyShowtime’s customer-centric focus and local market presence informs its approach to partnerships, content, and marketing. Once launched across more than 20 countries, SkyShowtime’s apps and content will be available in 18 different languages.
The content line up detailed in this press release is Nordic-specific and may vary per market.
For the trailer, please access here: https://youtu.be/ujzpT7FTeeY
For more details, please visit:
Website: www.skyshowtime.com
Newsroom: corporate.skyshowtime.com
LinkedIn: www.linkedin.com/company/skyshowtime
For further information, please email skyshowtimeenquiries@mcsaatchi.com
About SkyShowtime
SkyShowtime is a new streaming service that will launch in the Nordics on 20th September, this year.
A joint venture of Comcast Corporation (NASDAQ: CMCSA) and Paramount Global (NASDAQ: PARA, PARAA), SkyShowtime brings together the combined resources of both companies, direct-to-consumer experience, and the very best entertainment, movies, and original series from the iconic brands of Universal Pictures, DreamWorks, Sky Studios, Peacock, Paramount +, SHOWTIME®, Paramount Pictures and Nickelodeon.
SkyShowtime will be available in more than 20 European markets encompassing 90 million homes. It will be offered in Albania, Andorra, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Finland, Hungary, Kosovo, Montenegro, Netherlands, North Macedonia, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, and Sweden.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220905005022/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom